4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-25-034160
Options or other derivatives
- Director acquired 20,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Shahbazi Hamed Director | 2025-06-24 | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | D: show line 1 in the form |
Loading xslF345X05/wk-form4_1751553733.xml…